Ignite Creation Date:
2025-12-25 @ 5:03 AM
Ignite Modification Date:
2026-03-08 @ 3:31 AM
Study NCT ID:
NCT00553618
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2021-10-29
First Post:
2007-11-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients
Sponsor:
University of Louisville
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
07.0008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |